Biologicals

With the Biologicals ring test, the measurement of infliximab, adalimumab and vedolizumab levels is evaluated, as well as the detection of antibody levels against infliximab and adalimumab.

Contactperson

dr. D.J.A.R. Moes

Frequency

4 rounds of 3 samples

Number of participants

43

Price

Participation
€ 561.94
Additional sample set
€ 284.44
Additional cluster
€ 157.51

Details

Once a year, a clinical case is presented to the participants for evaluation of advisory skills

Supported analytes

Antibodies to Adalimumab ULN category
Antibodies to Infliximab ULN category
Vedolizumab

Methodelijst Biologicals

Antistoffen tegen Adalimumab ULN categorieConsensus methodegroep
Chemoluminescentie Chemiluminiscentie
ELISA Immunoassays
RIA Immunoassays
Overig Overige methodes
Antistoffen tegen infliximab ULN categorieConsensus methodegroep
Chemoluminescentie Chemiluminiscentie
ELISA Immunoassays
RIA Immunoassays
Overig Overige methodes
VedolizumabConsensus methodegroep
Chemoluminescentie Chemiluminiscentie
LC/MS(/MS) Chromatografie
ELISA Immunoassays
Overig Overige methodes

Questions about this scheme?

Use the form below to send us a message.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.